Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to FDA Applications sponsored by ALVOGEN MALTA
FDA Drug Application 020353 by ALVOGEN MALTA
Application Number
020353
Application Type
New Drug Application
Sponsor Applicant
ALVOGEN MALTA
Most Recent Label Available Flag
Current Patent Flag
Action Type
Approval
Chemical Type
New formulation
Therapeutic Potential
Standard
Orphan Code
Action Type
Duplicate Counter
Action Date
Document Type
Application Document ID
Sequence Number
Document Title
Document URL
Document Date
AP
0
1/5/1996
N
30640
000
http://www.fda.gov/downloads/Drugs/DrugSafety/UCM280324.pdf
11/17/2011
AP
0
3/28/1996
SLR
6461
001
http://www.accessdata.fda.gov/drugsatfda_docs/nda/96/020353s001_naprelan_toc.cfm
8/8/2003
AP
0
1/31/1997
SCS
AP
0
1/31/1997
SCE
AP
0
5/12/1997
SCE
AP
0
12/23/1997
SCP
AP
0
11/2/1999
SCS
AP
0
2/4/2002
SLR
AP
0
7/20/1999
SCP
AP
0
2/15/2000
SCP
AP
0
6/15/2000
SCS
AP
0
6/4/2001
SCP
AP
0
10/2/2001
SCM
AP
0
4/15/2002
SCS
AP
0
1/18/2006
SLR
13430
016
http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020353s016lbl.pdf
1/20/2006
AP
0
1/18/2006
SLR
13470
016
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020353s016ltr.pdf
1/20/2006
AP
0
5/29/2007
SLR
16678
019
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/020353s019ltr.pdf
6/4/2007
AP
0
7/8/2009
SCM
23153
023
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020353s023ltr.pdf
8/10/2009
AP
0
7/8/2009
SCM
23747
023
http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/20353s23lbl.pdf
11/6/2009
AP
0
11/8/2011
SLR
30542
028
http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020353s028lbl.pdf
11/9/2011
AP
0
11/8/2011
SLR
30546
028
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020353s028ltr.pdf
11/10/2011
AP
0
9/12/2014
SCM
AP
0
5/9/2016
SLR
45987
031
http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020353s031s032lbl.pdf
5/11/2016
AP
0
5/9/2016
SLR
46010
031
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/020353Orig1s031,s032ltr.pdf
5/12/2016
AP
0
5/9/2016
SLR
45988
032
http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020353s031s032lbl.pdf
5/11/2016
AP
0
5/9/2016
SLR
46011
032
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/020353Orig1s031,s032ltr.pdf
5/12/2016
Back to FDA Applications sponsored by ALVOGEN MALTA